|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Poseida Therapeutics, Inc.
| | | Phone: | (858)-779-3100 | Year Established: | 2015 | Main Contact: | Glenn Dourado, VP, Business Development | | Other Contacts: | Ryan Takeya, VP, Technical Operations Matthew Spear, M.D., CMO Nishan de Silva, M.D., President & COO Eric Ostertag, M.D., Ph.D., CEO
| | Company Description | Poseida Therapeutics is translating best-in-class gene editing technologies into lifesaving treatments. The company is developing CAR T-cell immunotherapies for multiple myeloma and other cancer types, as well as gene therapies for orphan diseases. Poseida has assembled a suite of industry-leading gene editing technologies, including the piggyBac™ DNA Modification System, XTN™ TALEN and NextGEN™ CRISPR site-specific nucleases, and Footprint-Free™ Gene Editing (FFGE). | |
|
|
|
|
|